1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Aesthetic Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Medical Aesthetic Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Medical Aesthetic Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Aesthetic Laser & Energy Devices
            6.3.1.1. Ablatives Skin Resurfacing Devices
            6.3.1.2. Non-ablative Skin Resurfacing Devices
        6.3.2. Skin Tightening & Body Contouring Devices
            6.3.2.1. Liposuction Devices
            6.3.2.2. Skin Tightening Devices
            6.3.2.3. Cellulite Reduction Devices
        6.3.3. Aesthetic Implants
            6.3.3.1. Breast Implants
            6.3.3.2. Soft Tissue Implants
            6.3.3.3. Aesthetic Dental Implants
            6.3.3.4. Others
        6.3.4. Facial Aesthetic Devices
            6.3.4.1. Microdermabrasion Devices
            6.3.4.2. Botulinum Toxin
            6.3.4.3. Dermal Fillers
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Aesthetic Devices Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Facial & Body Contouring
        7.3.2. Facial & Skin Rejuvenation
        7.3.3. Breast Enhancement
        7.3.4. Scar Treatment
        7.3.5. Reconstructive Surgery
        7.3.6. Tattoo Removal
        7.3.7. Hair Removal
    7.4. Market Attractiveness Analysis, by Application
8. Global Medical Aesthetic Devices Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Dermatology Clinics
        8.3.3. Cosmetic Centers
    8.4. Market Attractiveness Analysis, by Application
9. Global Medical Aesthetic Devices Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Medical Aesthetic Devices Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Product Type, 2017–2031
        10.3.1. Aesthetic Laser & Energy Devices
            10.3.1.1. Ablatives Skin Resurfacing Devices
            10.3.1.2. Non-ablative Skin Resurfacing Devices
        10.3.2. Skin Tightening & Body Contouring Devices
            10.3.2.1. Liposuction Devices
            10.3.2.2. Skin Tightening Devices
            10.3.2.3. Cellulite Reduction Devices
        10.3.3. Aesthetic Implants
            10.3.3.1. Breast Implants
            10.3.3.2. Soft Tissue Implants
            10.3.3.3. Aesthetic Dental Implants
            10.3.3.4. Others
        10.3.4. Facial Aesthetic Devices
            10.3.4.1. Microdermabrasion Devices
            10.3.4.2. Botulinum Toxin
            10.3.4.3. Dermal Fillers
    10.4. Market Value Forecast, by Application, 2017–2031
        10.4.1. Facial & Body Contouring
        10.4.2. Facial & Skin Rejuvenation
        10.4.3. Breast Enhancement
        10.4.4. Scar Treatment
        10.4.5. Reconstructive Surgery
        10.4.6. Tattoo Removal
        10.4.7. Hair Removal
    10.5. Market Value Forecast, by End-user, 2017–2031
        10.5.1. Hospitals
        10.5.2. Dermatology Clinics
        10.5.3. Cosmetic Centers
    10.6. Market Value Forecast, by Country, 2017–2031
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Product Type
        10.7.2. By Application
        10.7.3. By End-user
        10.7.4. By Country
11. Europe Medical Aesthetic Devices Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Product Type, 2017–2031
        11.3.1. Aesthetic Laser & Energy Devices
            11.3.1.1. Ablatives Skin Resurfacing Devices
            11.3.1.2. Non-ablative Skin Resurfacing Devices
        11.3.2. Skin Tightening & Body Contouring Devices
            11.3.2.1. Liposuction Devices
            11.3.2.2. Skin Tightening Devices
            11.3.2.3. Cellulite Reduction Devices
        11.3.3. Aesthetic Implants
            11.3.3.1. Breast Implants
            11.3.3.2. Soft Tissue Implants
            11.3.3.3. Aesthetic Dental Implants
            11.3.3.4. Others
        11.3.4. Facial Aesthetic Devices
            11.3.4.1. Microdermabrasion Devices
            11.3.4.2. Botulinum Toxin
            11.3.4.3. Dermal Fillers
    11.4. Market Value Forecast, by Application, 2017–2031
        11.4.1. Facial & Body Contouring
        11.4.2. Facial & Skin Rejuvenation
        11.4.3. Breast Enhancement
        11.4.4. Scar Treatment
        11.4.5. Reconstructive Surgery
        11.4.6. Tattoo Removal
        11.4.7. Hair Removal
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospitals
        11.5.2. Dermatology Clinics
        11.5.3. Cosmetic Centers
    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Product Type
        11.7.2. By Application
        11.7.3. By End-user
        11.7.4. By Country/Sub-region
12. Asia Pacific Medical Aesthetic Devices Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Product Type, 2017–2031
        12.3.1. Aesthetic Laser & Energy Devices
            12.3.1.1. Ablatives Skin Resurfacing Devices
            12.3.1.2. Non-ablative Skin Resurfacing Devices
        12.3.2. Skin Tightening & Body Contouring Devices
            12.3.2.1. Liposuction Devices
            12.3.2.2. Skin Tightening Devices
            12.3.2.3. Cellulite Reduction Devices
        12.3.3. Aesthetic Implants
            12.3.3.1. Breast Implants
            12.3.3.2. Soft Tissue Implants
            12.3.3.3. Aesthetic Dental Implants
            12.3.3.4. Others
        12.3.4. Facial Aesthetic Devices
            12.3.4.1. Microdermabrasion Devices
            12.3.4.2. Botulinum Toxin
            12.3.4.3. Dermal Fillers
    12.4. Market Value Forecast, by Application, 2017–2031
        12.4.1. Facial & Body Contouring
        12.4.2. Facial & Skin Rejuvenation
        12.4.3. Breast Enhancement
        12.4.4. Scar Treatment
        12.4.5. Reconstructive Surgery
        12.4.6. Tattoo Removal
        12.4.7. Hair Removal
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospitals
        12.5.2. Dermatology Clinics
        12.5.3. Cosmetic Centers
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Product Type
        12.7.2. By Application
        12.7.3. By End-user
        12.7.4. By Country/Sub-region
13. Latin America Medical Aesthetic Devices Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Product Type, 2017–2031
        13.3.1. Aesthetic Laser & Energy Devices
            13.3.1.1. Ablatives Skin Resurfacing Devices
            13.3.1.2. Non-ablative Skin Resurfacing Devices
        13.3.2. Skin Tightening & Body Contouring Devices
            13.3.2.1. Liposuction Devices
            13.3.2.2. Skin Tightening Devices
            13.3.2.3. Cellulite Reduction Devices
        13.3.3. Aesthetic Implants
            13.3.3.1. Breast Implants
            13.3.3.2. Soft Tissue Implants
            13.3.3.3. Aesthetic Dental Implants
            13.3.3.4. Others
        13.3.4. Facial Aesthetic Devices
            13.3.4.1. Microdermabrasion Devices
            13.3.4.2. Botulinum Toxin
            13.3.4.3. Dermal Fillers
    13.4. Market Value Forecast, by Application, 2017–2031
        13.4.1. Facial & Body Contouring
        13.4.2. Facial & Skin Rejuvenation
        13.4.3. Breast Enhancement
        13.4.4. Scar Treatment
        13.4.5. Reconstructive Surgery
        13.4.6. Tattoo Removal
        13.4.7. Hair Removal
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospitals
        13.5.2. Dermatology Clinics
        13.5.3. Cosmetic Centers
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Product Type
        13.7.2. By Application
        13.7.3. By End-user
        13.7.4. By Country/Sub-region
14. Middle East & Africa Medical Aesthetic Devices Market Analysis and Forecast
    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Product Type, 2017–2031
        14.3.1. Aesthetic Laser & Energy Devices
            14.3.1.1. Ablatives Skin Resurfacing Devices
            14.3.1.2. Non-ablative Skin Resurfacing Devices
        14.3.2. Skin Tightening & Body Contouring Devices
            14.3.2.1. Liposuction Devices
            14.3.2.2. Skin Tightening Devices
            14.3.2.3. Cellulite Reduction Devices
        14.3.3. Aesthetic Implants
            14.3.3.1. Breast Implants
            14.3.3.2. Soft Tissue Implants
            14.3.3.3. Aesthetic Dental Implants
            14.3.3.4. Others
        14.3.4. Facial Aesthetic Devices
            14.3.4.1. Microdermabrasion Devices
            14.3.4.2. Botulinum Toxin
            14.3.4.3. Dermal Fillers
    14.4. Market Value Forecast, by Application, 2017–2031
        14.4.1. Facial & Body Contouring
        14.4.2. Facial & Skin Rejuvenation
        14.4.3. Breast Enhancement
        14.4.4. Scar Treatment
        14.4.5. Reconstructive Surgery
        14.4.6. Tattoo Removal
        14.4.7. Hair Removal
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospitals
        14.5.2. Dermatology Clinics
        14.5.3. Cosmetic Centers
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Product Type
        14.7.2. By Application
        14.7.3. By End-user
        14.7.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Alma Lasers
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. AbbVie Inc.
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Cutera, Inc.
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Hologic, Inc.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Lumenis Ltd.
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Mentor Worldwide LLC (Johnson & Johnson)
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Solta Medical, Inc.
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Candela Corporation
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
        15.3.9. Merz Pharma GmbH & Co. KGaA
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Financial Overview
            15.3.9.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			